Belen Solans

20PUBLICATIONS
90CO-AUTHORS
Infant and child healthPharmacogenomicsMedical mycologyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 30, 2026
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35).

|Sep 24, 2026
Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

|Aug 20, 2026
Predicting tuberculosis relapse based on 28-day CFU, RS ratio, and/or drug contribution for novel regimens in the relapsing mouse model.

|Mar 30, 2026
Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-Line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis.

Tae Kyu Chung, Eunsol Yang, Maureen Shin

|Jan 08, 2026
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Ruvarashe J Madzime, Louvina van der Laan, Samantha du Toit

|Aug 12, 2025
Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis.

Belén P Solans, Ryo Miyakawa, Maureen Shin

Pageof 4

Frequent Collaborators

10 joint publications

Radojka M Savic

6 joint publications

Louvina van der Laan

3 joint publications

Anthony J Garcia-Prats

3 joint publications

Anneke Hesseling